Fazila Asmar

1.6k total citations
22 papers, 763 citations indexed

About

Fazila Asmar is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Fazila Asmar has authored 22 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Pathology and Forensic Medicine and 3 papers in Genetics. Recurrent topics in Fazila Asmar's work include Lymphoma Diagnosis and Treatment (10 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Fazila Asmar is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Fazila Asmar collaborates with scholars based in Denmark, United States and France. Fazila Asmar's co-authors include Kirsten Grønbæk, Søren G. F. Rasmussen, Ulrik Gether, Frank Guarnieri, Juan Antonio Ballesteros‐Cánovas, Anne D. Jensen, Lasse S. Kristensen, Peter de Nully Brown, Elisabeth Ralfkiær and Jesper Frank Christensen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Scientific Reports.

In The Last Decade

Fazila Asmar

22 papers receiving 755 citations

Peers

Fazila Asmar

PFM

ONCOL

CMN

Walter J. Jessen United States

Vidya Mamidipudi United States

Sonia Pagliardini Italy

Toshinori Iwahara Japan

María Teresa Calvo Spain

Shelli M. Morris United States

Niklas Ekman Finland

Huifei Liu United States

Delphine Bacq France

Walter J. Jessen United States

Fazila Asmar

471 ×0.9

95 ×0.7

PFM

77 ×0.6

100 ×0.9

ONCOL

46 ×0.4

CMN

Citations per year, relative to Fazila Asmar Fazila Asmar (= 1×) peers Walter J. Jessen

Countries citing papers authored by Fazila Asmar

Since Specialization

Citations

This map shows the geographic impact of Fazila Asmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fazila Asmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fazila Asmar more than expected).

Fields of papers citing papers by Fazila Asmar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fazila Asmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fazila Asmar. The network helps show where Fazila Asmar may publish in the future.

Co-authorship network of co-authors of Fazila Asmar

This figure shows the co-authorship network connecting the top 25 collaborators of Fazila Asmar. A scholar is included among the top collaborators of Fazila Asmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fazila Asmar. Fazila Asmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krogh, Nicolai, et al.. (2020). Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets. NAR Cancer. 2(4). zcaa035–zcaa035. 33 indexed citations

Hollander, Peter, Tatjana Pandzic, Larry Mansouri, et al.. (2019). Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma. American Journal of Hematology. 95(1). 57–67. 27 indexed citations

Ulff-Møller, Constance Jensina, Fazila Asmar, Yi Liu, et al.. (2018). Twin DNA Methylation Profiling Reveals Flare‐Dependent Interferon Signature and B Cell Promoter Hypermethylation in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 70(6). 878–890. 64 indexed citations

Reckzeh, Kristian, Montserrat Estruch, Amit Grover, et al.. (2018). Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin. Blood Advances. 2(13). 1628–1632. 11 indexed citations

Nielsen, Helene Myrtue, Christen Lykkegaard Andersen, Maj Westman, et al.. (2017). Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations. Scientific Reports. 7(1). 6774–6774. 14 indexed citations

Hansen, Jakob Werner, Christian Garde, Fazila Asmar, et al.. (2017). Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma. American Journal of Hematology. 92(7). 689–694. 38 indexed citations

Dimopoulos, Konstantinos, Lene Dissing Sjø, Jesper Frank Christensen, et al.. (2017). Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon‐independent manner. Molecular Oncology. 12(2). 180–195. 64 indexed citations

Asmar, Fazila, Konstantinos Dimopoulos, Peter de Nully Brown, et al.. (2016). TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy. Acta Neuropathologica Communications. 4(1). 40–40. 16 indexed citations

Asmar, Fazila, Christoffer Hother, Marianne Bach Treppendahl, et al.. (2014). Diffuse large B-cell lymphoma with combinedTP53mutation andMIR34Amethylation: Another “double hit” lymphoma with very poor outcome?. Oncotarget. 5(7). 1912–1925. 22 indexed citations

10.

Ralfkiær, Ulrik, Lene Dissing Sjø, Christoffer Hother, et al.. (2014). Differential Expression of miR-155 and miR-21 in Tumor and Stroma Cells in Diffuse Large B-Cell Lymphoma. Applied immunohistochemistry & molecular morphology. 23(3). 188–195. 9 indexed citations

11.

Fog, Cathrine K., Fazila Asmar, Christophé Côme, et al.. (2014). Loss of PRDM11 promotes MYC-driven lymphomagenesis. Blood. 125(8). 1272–1281. 20 indexed citations

12.

Larsen, Maria Torp, Andreas Glenthøj, Fazila Asmar, et al.. (2014). miRNA-130a regulates C/EBP-ε expression during granulopoiesis. Blood. 123(7). 1079–1089. 34 indexed citations

13.

Kristensen, Lasse S., Marianne Bach Treppendahl, Fazila Asmar, et al.. (2013). Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing. Scientific Reports. 3(1). 2789–2789. 30 indexed citations

14.

Asmar, Fazila, Vasu Punj, Jesper Frank Christensen, et al.. (2013). Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica. 98(12). 1912–1920. 103 indexed citations

15.

Andersen, Christen Lykkegaard, Fazila Asmar, Tobias Wirenfeldt Klausen, Hans Carl Hasselbalch, & Kirsten Grønbæk. (2012). Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones. Leukemia Research Reports. 2(1). 1–3. 30 indexed citations

16.

Hother, Christoffer, Fazila Asmar, Marianne Bach Treppendahl, et al.. (2012). miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A, and MIR34B/C. Blood. 120(21). 296–296. 2 indexed citations

17.

Asmar, Fazila, Jens Peter Christensen, Jens Vilstrup Johansen, et al.. (2011). TET2 mutations in Diffuse Large B-Cell Lymphoma: The Role of TET2 in the Regulation of Methylation Patterns at TET2 Target Genes. Blood. 118(21). 1364–1364. 1 indexed citations

18.

Grønbæk, Kirsten, Marianne Bach Treppendahl, Fazila Asmar, & Per Guldberg. (2008). Epigenetic Changes in Cancer as Potential Targets for Prophylaxis and Maintenance Therapy. Basic & Clinical Pharmacology & Toxicology. 103(5). 389–396. 23 indexed citations

19.

Gether, Ulrik, et al.. (2002). Structural Basis for Activation of G‐Protein‐Coupled Receptors. Pharmacology & Toxicology. 91(6). 304–312. 67 indexed citations

20.

Jensen, Anne D., Frank Guarnieri, Søren G. F. Rasmussen, et al.. (2001). Agonist-induced Conformational Changes at the Cytoplasmic Side of Transmembrane Segment 6 in the β2 Adrenergic Receptor Mapped by Site-selective Fluorescent Labeling. Journal of Biological Chemistry. 276(12). 9279–9290. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact